Citation Impact
Citing Papers
Estrogen receptor (ER)-β isoforms: A key to understanding ER-β signaling
2006
Sprouty 2, an Inhibitor of Mitogen-Activated Protein Kinase Signaling, Is Down-Regulated in Hepatocellular Carcinoma
2006
V600E BRAF is associated with disabled feedback inhibition of RAF–MEK signaling and elevated transcriptional output of the pathway
2009
Activation of NF-κB by TMPRSS2/ERG Fusion Isoforms through Toll-Like Receptor-4
2010
Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report
2016 Standout
Lack of activity of recombinant HIF prolyl hydroxylases (PHDs) on reported non-HIF substrates
2019 StandoutNobel
A survey of best practices for RNA-seq data analysis
2016 Standout
Disruption of the SRC-1 gene in mice suppresses breast cancer metastasis without affecting primary tumor formation
2008
Hallmarks of Cancer: The Next Generation
2011 Standout
FGFR3 mutations in prostate cancer: association with low-grade tumors
2009
Estrogen Receptors: How Do They Signal and What Are Their Targets
2007 Standout
Signaling pathway of MAPK/ERK in cell proliferation, differentiation, migration, senescence and apoptosis
2015 Standout
Regulation of Cellular Levels of Sprouty2 Protein by Prolyl Hydroxylase Domain and von Hippel-Lindau Proteins
2011
Berberine Improves Benign Prostatic Hyperplasia via Suppression of 5 Alpha Reductase and Extracellular Signal-Regulated Kinase in Vivo and in Vitro
2018
Derailed endocytosis: an emerging feature of cancer
2008
Pathological roles of MAPK signaling pathways in human diseases
2010 Standout
Targeting the ERK signaling pathway in cancer therapy
2006
Nuclear receptor coregulators as a new paradigm for therapeutic targeting
2010
Expression and functional role of negative signalling regulators in tumour development and progression
2010
Phytochemicals in Cancer Treatment: From Preclinical Studies to Clinical Practice
2020 Standout
Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation
2010 StandoutNature
Macrophage Diversity Enhances Tumor Progression and Metastasis
2010 Standout
The complexity of NF-κB signaling in inflammation and cancer
2013 Standout
MAP kinase signalling pathways in cancer
2007 Standout
From Krebs to clinic: glutamine metabolism to cancer therapy
2016 Standout
Fibroblast growth factor signalling: from development to cancer
2010 Standout
Pharmacological targeting of the HIF hydroxylases – A new field in medicine development
2016 StandoutNobel
Androgen action and metabolism in prostate cancer
2012
Concomitant down-regulation of SPRY1 and SPRY2 in prostate carcinoma
2006
EMT: 2016
2016 Standout
ERK MAP kinase in G1 cell cycle progression and cancer
2006
Andrographolide Targets Androgen Receptor Pathway in Castration-Resistant Prostate Cancer
2011
Pterostilbene-Isothiocyanate Conjugate Suppresses Growth of Prostate Cancer Cells Irrespective of Androgen Receptor Status
2014
Sprouty proteins: multifaceted negative-feedback regulators of receptor tyrosine kinase signaling
2005
3Omics: a web-based systems biology tool for analysis, integration and visualization of human transcriptomic, proteomic and metabolomic data
2013
Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms
2013 Standout
Inhibition of mTORC1 leads to MAPK pathway activation through a PI3K-dependent feedback loop in human cancer
2008 Standout
β-Arrestin and Mdm2 Mediate IGF-1 Receptor-stimulated ERK Activation and Cell Cycle Progression
2007 StandoutNobel
Andrographolide and its analogues: versatile bioactive molecules for combating inflammation and cancer
2011 Standout
Paths of FGFR-driven tumorigenesis
2009
Normal and cancer-related functions of the p160 steroid receptor co-activator (SRC) family
2009
The role of fibroblast growth factors and their receptors in prostate cancer
2004
Mechanisms of implantation: strategies for successful pregnancy
2012 Standout
The Fibroblast Growth Factor signaling pathway
2015 Standout
Coactivator SRC-2–dependent metabolic reprogramming mediates prostate cancer survival and metastasis
2015
EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals
2015 Standout
The MAPK pathway across different malignancies: A new perspective
2014 Standout
Molecular characterization of the stomach microbiota in patients with gastric cancer and in controls
2009
Enzalutamide for the Treatment of Prostate Cancer: Results and Implications of the AFFIRM Trial
2014
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Epigenetic plasticity: A central regulator of epithelial-to-mesenchymal transition in cancer
2014
PHD3-mediated prolyl hydroxylation of nonmuscle actin impairs polymerization and cell motility
2014 StandoutNobel
Thyroid Hormone Regulation of Metabolism
2014 Standout
Nuclear Receptor Coactivators: Master Regulators of Human Health and Disease
2013
MetaboAnalyst 5.0: narrowing the gap between raw spectra and functional insights
2021 Standout
Works of Ajula Vaid being referenced
Androgens Modulate Expression of Transcription Intermediary Factor 2, an Androgen Receptor Coactivator whose Expression Level Correlates with Early Biochemical Recurrence in Prostate Cancer
2006
Association Between Gastric Atrophy and Helicobacter pylori Infection in Japanese Children: A Retrospective Multicenter Study
2006
Role of SRC-1 in the Promotion of Prostate Cancer Cell Growth and Tumor Progression
2005
The Expression of Sprouty1, an Inhibitor of Fibroblast Growth Factor Signal Transduction, Is Decreased in Human Prostate Cancer
2004